P&K Skin Research Center Co Ltd
KOSDAQ:347740
Income Statement
Earnings Waterfall
P&K Skin Research Center Co Ltd
Income Statement
P&K Skin Research Center Co Ltd
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||
| Interest Expense |
5
|
11
|
17
|
22
|
23
|
26
|
28
|
30
|
31
|
29
|
28
|
26
|
26
|
0
|
22
|
33
|
24
|
31
|
28
|
26
|
29
|
37
|
45
|
|
| Revenue |
13 690
N/A
|
14 676
+7%
|
18 156
+24%
|
14 676
-19%
|
14 785
+1%
|
15 863
+7%
|
16 207
+2%
|
17 487
+8%
|
17 229
-1%
|
16 360
-5%
|
16 702
+2%
|
17 957
+8%
|
17 740
-1%
|
16 602
-6%
|
15 766
-5%
|
14 843
-6%
|
15 500
+4%
|
16 283
+5%
|
17 671
+9%
|
17 847
+1%
|
20 121
+13%
|
21 794
+8%
|
22 131
+2%
|
|
| Gross Profit | ||||||||||||||||||||||||
| Cost of Revenue |
(3 617)
|
(4 040)
|
(4 969)
|
(4 346)
|
(4 740)
|
(5 411)
|
(5 978)
|
(6 189)
|
(6 145)
|
(6 054)
|
(6 262)
|
(6 844)
|
(7 160)
|
(7 228)
|
(7 309)
|
(7 644)
|
(8 030)
|
(8 277)
|
(9 053)
|
(9 371)
|
(10 429)
|
(11 464)
|
(11 831)
|
|
| Gross Profit |
10 073
N/A
|
10 637
+6%
|
13 187
+24%
|
10 331
-22%
|
10 045
-3%
|
10 451
+4%
|
10 229
-2%
|
11 298
+10%
|
11 083
-2%
|
10 305
-7%
|
10 440
+1%
|
11 113
+6%
|
10 581
-5%
|
9 374
-11%
|
8 457
-10%
|
7 199
-15%
|
7 470
+4%
|
8 006
+7%
|
8 618
+8%
|
8 476
-2%
|
9 692
+14%
|
10 330
+7%
|
10 299
0%
|
|
| Operating Income | ||||||||||||||||||||||||
| Operating Expenses |
(3 579)
|
(3 470)
|
(4 211)
|
(3 114)
|
(3 231)
|
(3 813)
|
(4 396)
|
(4 837)
|
(5 267)
|
(5 200)
|
(5 278)
|
(5 473)
|
(5 615)
|
(5 821)
|
(5 903)
|
(5 820)
|
(5 953)
|
(5 888)
|
(5 830)
|
(5 894)
|
(5 853)
|
(6 123)
|
(6 372)
|
|
| Selling, General & Administrative |
(2 403)
|
(2 325)
|
(2 803)
|
(2 009)
|
(2 112)
|
(2 575)
|
(2 970)
|
(3 316)
|
(3 622)
|
(3 527)
|
(3 551)
|
(3 517)
|
(3 639)
|
(3 856)
|
(4 025)
|
(4 052)
|
(4 114)
|
(3 986)
|
(3 884)
|
(3 951)
|
(3 899)
|
(4 139)
|
(4 353)
|
|
| Research & Development |
(933)
|
(894)
|
(1 091)
|
(853)
|
(884)
|
(998)
|
(1 185)
|
(1 262)
|
(1 362)
|
(1 390)
|
(1 440)
|
(1 670)
|
(1 675)
|
(1 636)
|
(1 508)
|
(1 357)
|
(1 400)
|
(1 457)
|
(1 512)
|
(1 519)
|
(1 537)
|
(1 559)
|
(1 586)
|
|
| Depreciation & Amortization |
(244)
|
(251)
|
(317)
|
(252)
|
(235)
|
(240)
|
(242)
|
(259)
|
(284)
|
(283)
|
(287)
|
(286)
|
(301)
|
(329)
|
(370)
|
(411)
|
(439)
|
(444)
|
(434)
|
(424)
|
(417)
|
(425)
|
(434)
|
|
| Operating Income |
6 493
N/A
|
7 167
+10%
|
8 975
+25%
|
7 217
-20%
|
6 814
-6%
|
6 639
-3%
|
5 833
-12%
|
6 461
+11%
|
5 816
-10%
|
5 106
-12%
|
5 161
+1%
|
5 640
+9%
|
4 965
-12%
|
3 553
-28%
|
2 554
-28%
|
1 379
-46%
|
1 517
+10%
|
2 118
+40%
|
2 788
+32%
|
2 582
-7%
|
3 839
+49%
|
4 206
+10%
|
3 927
-7%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||
| Interest Income Expense |
282
|
229
|
321
|
356
|
637
|
916
|
1 202
|
1 511
|
1 526
|
1 437
|
1 617
|
2 004
|
2 693
|
2 976
|
3 342
|
3 915
|
3 821
|
4 059
|
5 240
|
4 440
|
4 501
|
4 775
|
4 113
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(1)
|
|
| Total Other Income |
295
|
315
|
343
|
210
|
316
|
323
|
437
|
553
|
484
|
395
|
558
|
547
|
536
|
445
|
158
|
63
|
(35)
|
(41)
|
(97)
|
(224)
|
(233)
|
(215)
|
(193)
|
|
| Pre-Tax Income |
7 070
N/A
|
7 711
+9%
|
9 640
+25%
|
7 782
-19%
|
7 767
0%
|
7 877
+1%
|
7 473
-5%
|
8 526
+14%
|
7 826
-8%
|
6 937
-11%
|
7 336
+6%
|
8 190
+12%
|
8 193
+0%
|
6 973
-15%
|
6 054
-13%
|
5 357
-12%
|
5 303
-1%
|
6 135
+16%
|
7 931
+29%
|
6 797
-14%
|
8 107
+19%
|
8 769
+8%
|
7 849
-10%
|
|
| Net Income | ||||||||||||||||||||||||
| Tax Provision |
(1 063)
|
(1 142)
|
(1 408)
|
(1 063)
|
(1 018)
|
(1 032)
|
(974)
|
(1 233)
|
(1 133)
|
(891)
|
(918)
|
(1 060)
|
(1 050)
|
(948)
|
(813)
|
(657)
|
(727)
|
(903)
|
(1 291)
|
(1 097)
|
(1 357)
|
(1 461)
|
(1 278)
|
|
| Income from Continuing Operations |
6 007
|
6 570
|
8 232
|
6 719
|
6 749
|
6 845
|
6 499
|
7 293
|
6 693
|
6 046
|
6 418
|
7 130
|
7 143
|
6 025
|
5 241
|
4 700
|
4 576
|
5 232
|
6 640
|
5 701
|
6 750
|
7 309
|
6 571
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
55
|
82
|
113
|
121
|
124
|
123
|
116
|
109
|
81
|
76
|
|
| Net Income (Common) |
6 007
N/A
|
6 570
+9%
|
8 232
+25%
|
6 719
-18%
|
6 749
+0%
|
6 845
+1%
|
6 499
-5%
|
7 293
+12%
|
6 693
-8%
|
6 046
-10%
|
6 418
+6%
|
7 130
+11%
|
7 170
+1%
|
6 080
-15%
|
5 323
-12%
|
4 813
-10%
|
4 697
-2%
|
5 356
+14%
|
6 763
+26%
|
5 816
-14%
|
6 859
+18%
|
7 390
+8%
|
6 647
-10%
|
|
| EPS (Diluted) |
984.74
N/A
|
1 094.92
+11%
|
1 286.17
+17%
|
1 119.83
-13%
|
911.5
-19%
|
231.13
-75%
|
219.43
-5%
|
246.22
+12%
|
225.82
-8%
|
203.92
-10%
|
214.12
+5%
|
239.12
+12%
|
238.92
0%
|
202.6
-15%
|
177.36
-12%
|
160.48
-10%
|
156.5
-2%
|
185.33
+18%
|
234.17
+26%
|
200.32
-14%
|
237.46
+19%
|
255.87
+8%
|
230.14
-10%
|
|